SK BIOPHARMACEUTICALS earnings per share and revenue

326030 earnings per share for the last quarter are 2380.32 KRW whereas the estimation was 197.19 KRW which accounts for 1107.12% surprise. Company revenue for the same period amounts to 163.00 B KRW despite the estimated figure of 153.96 B KRW. Estimated earnings per share for the next quarter are 267.84 KRW, and revenue is expected to reach 155.35 B KRW. Also watch annual changes over time to get a bigger picture of 326030 earnings per share and revenue dynamics.